Sanofi India Limited (BOM: 500674)
7,372.30
+52.40 (0.72%)
At close: Sep 10, 2024
Sanofi India Income Statement
Financials in millions INR. Fiscal year is January - December.
Millions INR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 27,893 | 28,511 | 27,701 | 29,566 | 29,019 | 30,706 | Upgrade
|
Revenue Growth (YoY) | -0.61% | 2.92% | -6.31% | 1.88% | -5.49% | 10.82% | Upgrade
|
Cost of Revenue | 11,931 | 12,186 | 12,053 | 13,235 | 12,790 | 13,787 | Upgrade
|
Gross Profit | 15,962 | 16,325 | 15,648 | 16,331 | 16,229 | 16,919 | Upgrade
|
Selling, General & Admin | 4,055 | 4,126 | 4,414 | 4,836 | 5,164 | 5,446 | Upgrade
|
Other Operating Expenses | 4,047 | 4,123 | 4,157 | 3,869 | 3,905 | 4,798 | Upgrade
|
Operating Expenses | 8,499 | 8,645 | 8,990 | 9,372 | 9,891 | 11,243 | Upgrade
|
Operating Income | 7,463 | 7,680 | 6,658 | 6,959 | 6,338 | 5,676 | Upgrade
|
Interest Expense | -14 | -17 | -17 | -18 | -18 | -3 | Upgrade
|
Interest & Investment Income | 475 | 475 | 589 | 631 | 780 | 910 | Upgrade
|
Currency Exchange Gain (Loss) | 16 | 16 | 2 | 5 | - | 17 | Upgrade
|
Other Non Operating Income (Expenses) | -183 | 147 | 122 | 41 | 117 | 11 | Upgrade
|
EBT Excluding Unusual Items | 7,757 | 8,301 | 7,354 | 7,618 | 7,217 | 6,611 | Upgrade
|
Merger & Restructuring Charges | -457 | -77 | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -37 | -37 | -2 | 66 | -28 | -612 | Upgrade
|
Asset Writedown | - | - | -29 | - | - | - | Upgrade
|
Other Unusual Items | 13 | 268 | 1,320 | 4,892 | -417 | - | Upgrade
|
Pretax Income | 7,276 | 8,455 | 8,643 | 12,576 | 6,772 | 5,999 | Upgrade
|
Income Tax Expense | 1,988 | 2,426 | 2,437 | 3,132 | 1,996 | 1,857 | Upgrade
|
Earnings From Continuing Operations | 5,288 | 6,029 | 6,206 | 9,444 | 4,776 | 4,142 | Upgrade
|
Net Income | 5,294 | 6,029 | 6,206 | 9,444 | 4,776 | 4,142 | Upgrade
|
Net Income to Common | 5,294 | 6,029 | 6,206 | 9,444 | 4,776 | 4,142 | Upgrade
|
Net Income Growth | -7.95% | -2.85% | -34.29% | 97.74% | 15.31% | 8.83% | Upgrade
|
Shares Outstanding (Basic) | 23 | 23 | 23 | 23 | 23 | 23 | Upgrade
|
Shares Outstanding (Diluted) | 23 | 23 | 23 | 23 | 23 | 23 | Upgrade
|
Shares Change (YoY) | 0.00% | - | - | - | - | - | Upgrade
|
EPS (Basic) | 229.86 | 261.78 | 269.47 | 410.06 | 207.38 | 179.85 | Upgrade
|
EPS (Diluted) | 229.86 | 261.78 | 269.47 | 410.06 | 207.38 | 179.85 | Upgrade
|
EPS Growth | -7.95% | -2.85% | -34.29% | 97.74% | 15.31% | 8.83% | Upgrade
|
Free Cash Flow | 2,873 | 1,961 | 3,765 | 5,358 | 5,697 | 3,365 | Upgrade
|
Free Cash Flow Per Share | 124.74 | 85.15 | 163.48 | 232.65 | 247.37 | 146.11 | Upgrade
|
Dividend Per Share | - | 167.000 | 194.000 | 181.000 | 125.000 | 106.000 | Upgrade
|
Dividend Growth | - | -13.92% | 7.18% | 44.80% | 17.92% | 26.19% | Upgrade
|
Gross Margin | 57.23% | 57.26% | 56.49% | 55.24% | 55.93% | 55.10% | Upgrade
|
Operating Margin | 26.76% | 26.94% | 24.04% | 23.54% | 21.84% | 18.48% | Upgrade
|
Profit Margin | 18.98% | 21.15% | 22.40% | 31.94% | 16.46% | 13.49% | Upgrade
|
Free Cash Flow Margin | 10.30% | 6.88% | 13.59% | 18.12% | 19.63% | 10.96% | Upgrade
|
EBITDA | 7,776 | 7,992 | 6,984 | 7,537 | 7,091 | 6,659 | Upgrade
|
EBITDA Margin | 27.88% | 28.03% | 25.21% | 25.49% | 24.44% | 21.69% | Upgrade
|
D&A For EBITDA | 313 | 312 | 326 | 578 | 753 | 983 | Upgrade
|
EBIT | 7,463 | 7,680 | 6,658 | 6,959 | 6,338 | 5,676 | Upgrade
|
EBIT Margin | 26.76% | 26.94% | 24.04% | 23.54% | 21.84% | 18.48% | Upgrade
|
Effective Tax Rate | 27.32% | 28.69% | 28.20% | 24.90% | 29.47% | 30.96% | Upgrade
|
Revenue as Reported | 28,216 | 29,164 | 28,416 | 30,310 | 29,917 | 31,647 | Upgrade
|
Advertising Expenses | - | 409 | 338 | 461 | 502 | 798 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.